SCHEMBL5498487

SCHEMBL5498487

[CH2]NCc1cncc(-c2ccc(F)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.50
DRD4 P21917 7/20 0.50
DRD3 P35462 7/20 0.50
HTR1A P08908 2/20 0.47
GPR55 Q9Y2T6 2/20 0.44
KCNH2 Q12809 3/20 0.43
CYP11B1 P15538 3/20 0.43
CYP11B2 P19099 3/20 0.43
CYP2D6 P10635 1/20 0.40
GRIN2B Q13224 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5498490 0.85 NOS3 (0.49) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL8625514 0.84 CYP11B1 (0.50) DRD2DRD4DRD3HTR1AKCNH2
SCHEMBL5973289 0.82 HTR1A (0.50) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL7395929 0.80 HTR1A (0.48) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL1582822 0.79 CYP11B1 (0.59) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL4197241 0.79 DRD2 (0.52) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL16135138 0.79 GPR55 (0.59) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL10528007 0.79 DRD2 (0.52) DRD2DRD4DRD3HTR1AGPR55
SCHEMBL7393289 0.79 DRD2 (0.52) DRD2DRD4DRD3GPR55CYP11B1
SCHEMBL15605482 0.77 KCNH2 (0.67) DRD2DRD4DRD3HTR1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5767132-A CENTRAL NERVOUS SYSTEM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-06-16 US claimed
EP-1408964-B1 USE OF 2- 5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL|-CHROMANE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS MERCK PATENT GMBH (DE) 2007-01-24 EP disclosed
US-5767132-A CENTRAL NERVOUS SYSTEM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-06-16 US disclosed